People: Alnylam Pharmaceuticals Inc (ALNY.O)

ALNY.O on Nasdaq

77.69USD
17 Sep 2014
Price Change (% chg)

$4.23 (+5.76%)
Prev Close
$73.46
Open
$74.08
Day's High
$78.25
Day's Low
$74.04
Volume
964,687
Avg. Vol
686,096
52-wk High
$112.57
52-wk Low
$47.03

Search Stocks

Reid, Laurence 

Brief Biography

Dr. Laurence E. Reid, Ph.D., is Senior Vice President, Chief Business Officer of Alnylam Pharmaceuticals, Inc. From January 2006 through May 2010, Dr. Reid served as the Chief Business Officer at Ensemble Therapeutics, a biotechnology company. Prior to joining Ensemble Therapeutics, Dr. Reid worked as a founder of two start-up companies in the fields of stem cell therapeutics and inflammation. Dr. Reid previously spent ten years at Millennium Pharmaceuticals, Inc., a biopharmaceutical company, from 1993 through 2003, where he served in a range of general management and business development positions, including General Manager of Millennium UK with responsibility for Millennium’s European operations, Vice President of Business Development and Strategic Planning for the company’s predictive medicine efforts, as well as in pharmaceutical business development and technology acquisition.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
561,250 -- 652,336 1,213,590

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 27,252 890,484.00
Name Fiscal Year Total

John Clarke

--

Barry Greene

3,983,370

John Maraganore

6,236,120

Akshay Vaishnaw

1,747,850

Laurence Reid

1,213,590

Michael Mason

500,850
As Of 30 Dec 2013
Search Stocks